Small but mighty

Summary: GPT Healthcare is quietly building a profitable niche with its mid-sized, cash-rich hospitals across Eastern India. Its asset-light expansion, improving ARPOB and strong cash flow could fuel mid-teens growth—if execution stays steady. Investors may be underestimating this small-cap’s potential. In a world of gleaming super-speciality campuses, GPT Healthcare is betting small. Its ILS Hospitals are modest, with 100 to 200 beds each, spread across Eastern India, where organised healthcare supply still lags demand. The company’s model is lean, asset-light and cash-rich. Yet, its stock tells a harsher story: down 24 per cent since listing in February 2024, even as bigger chains have raced ahead. At 25 times earnings, the market seems unconvinced. But is this a discount for being small, or an opening for investors willing to see beyond scale? A compact model GPT runs a network of modestly sized multi-speciality hospitals: three in Kolkata (Salt Lake, Dum Dum, Howrah), one in Agartala and a newly launched facility in Raipur. In FY25, the four operating hospitals together generated Rs 407 crore in revenue, with network occupancy at 53 per cent and ARPOB (average revenue per occupied bed) at Rs 37,180. Importantly, the business is largely cash-driven, with private and insurance patients dominating and minimal reliance on government schemes. This keeps debtor days low and cash conversion high for GPT Healthcare. Why the discount? Smaller hospitals tend to produce lumpier numbers. Occ